Delivery Order SPE2DB20D1100-SPE2DB24FB1Z6

Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,048.80 Firm Fixed Price delivery order contract is for the supply of 4,567,198,853 units of Dextroamphetamine-Amphetamine 20 mg tablets. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,074.66 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,714,607 tablets of dextroamphetamine-amphetamine 10 mg. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,026.75, is for the delivery of 4,567,426,586 units of 20 mg dextroamphetamine-amphetamine tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 3, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.35 firm fixed-price delivery order contract is for the supply of 4566203473 Dextroamphetamine-Amphetamine 20 mg tablets in 100-count bottles. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,926.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,285,738 units of dextroamphetamine-amphetamine 15 mg tablets, with a completion date of October 31, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for 4,563,829,899 tablets of dextroamphetamine-amphetamine 10 mg capsules, with a potential value of $1,320.00 and a completion date of March 4, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,437,612 units of 10 mg dextroamphetamine-amphetamine tablets. The delivery order, valued at $1,290.54, was issued by the Defense Logistics Agency (DLA) and has a completion date of April 30, 2024. The contract is a firm-fixed price Indefinite Delivery Contract (IDC) that allows the DLA to efficiently procure essential pharmaceutical products and medical supplies for military...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,740.39 firm fixed-price delivery order is for the supply of 4,565,495,385 units of dextroamphetamine-amphetamine 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,601,061 units of Dextroamphetamine-Amphetamine 10 mg tablets in 100-count bottles. The award, valued at $1,184.59, is a firm fixed-price delivery order contract with a completion date of September 26, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,522.13 Delivery Order awarded by the Defense Logistics Agency (DLA) for the supply of 4558973314 - Dextroamphetamine-Amphetamine 10 mg tablets. The award has a firm fixed price and an ultimate completion date of November 3, 2022. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB1Z6
    Delivery Order

This federal contract award, valued at $1,467.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564234212 Dextroamphetamine-Amphetamine 20 mg tablets in 100-count bottles. This is a firm fixed price delivery order with an ultimate completion date of April 11, 2024.

Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The award does not have a set-aside designation.

Generated 7/10/24, 9:05 AM